# Improving quality outcomes via process improvements and innovation: the largest single-surgeon series of 1,701 consecutive robotic lobectomy and segmentectomy cases

**Authors:** Robert J. Cerfolio, Natalie A. Ostro, Ashley J. McCormack

PMC · DOI: 10.3389/fsurg.2025.1589149 · Frontiers in Surgery · 2025-04-24

## TL;DR

A single surgeon's experience with 1,701 robotic lung surgeries shows that process improvements and innovation can significantly enhance patient outcomes and satisfaction.

## Contribution

The paper presents the largest single-surgeon series of robotic lobectomy and segmentectomy, demonstrating scalable process improvements that enhance surgical outcomes.

## Key findings

- Conversion rates, 90-day mortality, and major morbidity significantly decreased over time.
- Operative times, length of stay, and chest tube duration improved with process innovations.
- High patient satisfaction and efficient lymph node resection were achieved in cancer cases.

## Abstract

Our goal is to continuously improve patient outcomes, care quality, and overall experience.

This is a quality improvement study based on the experience of a single surgeon and represents the world's largest reported consecutive series of robotic lobectomy and segmentectomy performed by a single surgeon.

From 1 January 2009 to 31 December 2024, a total of 1,701 patients (52% women) were treated, of whom 1,138 underwent robotic lobectomy (1,094, 96.1% were completed robotically) and 563 patients underwent segmentectomy (561, 99.6% were completed robotically). Quality metrics improved over each quartile: conversion rates decreased from 13 patients in our first 62 operations to 1 in our last 600 patients (p < 0.001), 90-day mortality decreased from 0.3% to 0% (p < 0.001), and major morbidity decreased from 6% to 1% (p < 0.001). Among patients with cancer, 99% underwent an R0 resection, with a median of five N2 and two N1 lymph node stations resected, 24 lymph nodes removed, and blood loss of 20 cc. Efficiency metrics improved with medians as follows: length of stay decreased from 110  to 26 h (p < 0.001), operative times fell from 125 to 93 min (p < 0.001), chest tube duration decreased from 72  to 4 h, and patient satisfaction scores improved from 87% to 98%. Various selective process improvements and strategies that we implemented and, in our opinion, improved both patient outcomes and experience are shared to scale this experience to others.

A commitment to getting better via innovation and process improvements of all aspects of the pre-, intra-, and postoperative care and their pathways leads to improved outcomes and patient experience for robotic pulmonary resection. The selective processes and strategies that we believe led to these improving outcomes are shared and are possibly scalable elsewhere.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** cancer (MESH:D009369), blood loss (MESH:D016063)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12058782/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12058782/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12058782/full.md

---
Source: https://tomesphere.com/paper/PMC12058782